Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.0086 | 0.0836 | 0.0836 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0198 | 0.2866 | 0.258 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.059 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.059 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0124 | 0.1529 | 0.1529 |
Loa Loa (eye worm) | hypothetical protein | 0.0112 | 0.1297 | 0.1252 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0504 | 0.8431 | 0.8431 |
Trichomonas vaginalis | fk506-binding protein, putative | 0.0062 | 0.0385 | 0.0385 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.0231 | 0.018 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0469 | 0.7804 | 0.7804 |
Trypanosoma brucei | phosphatidylinositol 3-kinase tor, putative | 0.0279 | 0.4343 | 0.4116 |
Schistosoma mansoni | immunophilin | 0.0053 | 0.0231 | 0.0109 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.059 | 1 | 1 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.059 | 1 | 1 |
Plasmodium falciparum | peptidyl-prolyl cis-trans isomerase FKBP35 | 0.0062 | 0.0385 | 0.5 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase, putative | 0.0112 | 0.1297 | 0.0948 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0439 | 0.725 | 1 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0112 | 0.1297 | 0.0948 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.059 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0319 | 0.5062 | 0.5062 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0439 | 0.725 | 0.725 |
Plasmodium vivax | 70 kDa peptidylprolyl isomerase, putative | 0.0062 | 0.0385 | 0.5 |
Echinococcus granulosus | serine:threonine protein kinase SMG1 | 0.0112 | 0.1297 | 0.1252 |
Echinococcus granulosus | PIK kinase FAT and Armadillo domain containing protein | 0.0086 | 0.0836 | 0.0789 |
Leishmania major | target of rapamycin kinase (TOR) kinase 3 | 0.047 | 0.7813 | 0.7725 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0198 | 0.2866 | 0.2829 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0112 | 0.1297 | 0.1252 |
Loa Loa (eye worm) | hypothetical protein | 0.0086 | 0.0836 | 0.0789 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0319 | 0.5062 | 0.5062 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0469 | 0.7804 | 0.7804 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0396 | 0.6466 | 0.6466 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0439 | 0.725 | 0.725 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0318 | 0.5053 | 0.5053 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0349 | 0.5617 | 0.5617 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0353 | 0.568 | 0.568 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0439 | 0.725 | 0.725 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0158 | 0.2146 | 0.2146 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0439 | 0.725 | 0.725 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0074 | 0.0604 | 0.0604 |
Loa Loa (eye worm) | hypothetical protein | 0.012 | 0.1454 | 0.141 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0383 | 0.6234 | 0.6234 |
Mycobacterium ulcerans | FK-506 binding protein, peptidyl-prolyl cis-trans isomerase | 0.0062 | 0.0385 | 0.5 |
Schistosoma mansoni | immunophilin | 0.0062 | 0.0385 | 0.0265 |
Schistosoma mansoni | phosphatidylinositol 3-and 4-kinase | 0.0198 | 0.2866 | 0.2777 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0439 | 0.725 | 0.725 |
Schistosoma mansoni | hypothetical protein | 0.0086 | 0.0836 | 0.0721 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0198 | 0.2866 | 0.258 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.059 | 1 | 1 |
Trichomonas vaginalis | peptidylprolyl isomerase, putative | 0.0062 | 0.0385 | 0.0385 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0198 | 0.2866 | 0.2866 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0112 | 0.1297 | 0.1297 |
Loa Loa (eye worm) | hypothetical protein | 0.0074 | 0.0604 | 0.0555 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0112 | 0.1297 | 0.1297 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.059 | 1 | 1 |
Schistosoma mansoni | immunophilin | 0.0062 | 0.0385 | 0.0265 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.059 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0124 | 0.1529 | 0.1485 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.047 | 0.7813 | 0.7725 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.059 | 1 | 1 |
Treponema pallidum | peptidyl-prolyl cis-trans isomerase, FKBP-type, 22 kDa (fklB) | 0.0062 | 0.0385 | 0.5 |
Trypanosoma brucei | FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative | 0.0245 | 0.3725 | 0.3473 |
Loa Loa (eye worm) | FKBP5 protein | 0.0062 | 0.0385 | 0.0335 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.059 | 1 | 1 |
Toxoplasma gondii | non-specific serine/threonine protein kinase | 0.0124 | 0.1529 | 0.039 |
Echinococcus multilocularis | PIK kinase, FAT and Armadillo domain containing protein | 0.0086 | 0.0836 | 0.0789 |
Echinococcus multilocularis | serine:threonine protein kinase SMG1 | 0.0112 | 0.1297 | 0.1252 |
Leishmania major | phosphatidylinositol 3-kinase, putative | 0.0198 | 0.2866 | 0.258 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0198 | 0.2866 | 0.2866 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0353 | 0.568 | 0.568 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0198 | 0.2866 | 0.258 |
Leishmania major | phosphatidylinositol 3-related kinase, putative | 0.0198 | 0.2866 | 0.258 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.059 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.059 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0112 | 0.1297 | 0.0948 |
Echinococcus multilocularis | peptidyl prolyl cis trans isomerase FKBP4 | 0.0062 | 0.0385 | 0.0335 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0469 | 0.7804 | 0.7804 |
Echinococcus multilocularis | serine protein kinase ATM | 0.0112 | 0.1297 | 0.1252 |
Echinococcus granulosus | phosphatidylinositol 3 and 4 kinase | 0.0198 | 0.2866 | 0.2829 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.059 | 1 | 1 |
Schistosoma mansoni | fkbp-rapamycin associated protein | 0.0112 | 0.1297 | 0.1188 |
Leishmania major | target of rapamycin (TOR) kinase 1, putative | 0.059 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0198 | 0.2866 | 0.2866 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0198 | 0.2866 | 0.2866 |
Echinococcus granulosus | peptidyl prolyl cis trans isomerase FKBP4 | 0.0053 | 0.0231 | 0.018 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0198 | 0.2866 | 0.2866 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0198 | 0.2866 | 0.258 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0074 | 0.0604 | 0.0604 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0112 | 0.1297 | 0.1297 |
Trypanosoma brucei | phosphatidylinositol kinase related protein, putative | 0.0112 | 0.1297 | 0.0948 |
Schistosoma mansoni | immunophilin FK506 binding protein FKBP12 | 0.0062 | 0.0385 | 0.0265 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0469 | 0.7804 | 0.7804 |
Brugia malayi | FKBP-type peptidyl-prolyl cis-trans isomerase-12, BmFKBP-12 | 0.0062 | 0.0385 | 0.0335 |
Echinococcus multilocularis | peptidyl prolyl cis trans isomerase FKBP4 | 0.0053 | 0.0231 | 0.018 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0112 | 0.1297 | 0.1252 |
Echinococcus granulosus | serine protein kinase ATM | 0.0112 | 0.1297 | 0.1252 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0439 | 0.725 | 0.725 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0319 | 0.5062 | 0.5062 |
Loa Loa (eye worm) | FKBP-type peptidyl-prolyl cis-trans isomerase-12 | 0.0062 | 0.0385 | 0.0335 |
Entamoeba histolytica | protein kinase rad3, putative | 0.0112 | 0.1297 | 0.0948 |
Leishmania major | target of rapamycin (TOR) kinase 2, putative | 0.059 | 1 | 1 |
Brugia malayi | FKBP-type peptidyl-prolyl cis-trans isomerase-59, BmFKBP59 | 0.0062 | 0.0385 | 0.0335 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0439 | 0.725 | 0.725 |
Echinococcus multilocularis | fk506 binding protein | 0.0062 | 0.0385 | 0.0335 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0349 | 0.5617 | 0.5617 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0198 | 0.2866 | 0.2829 |
Echinococcus multilocularis | phosphatidylinositol 3 and 4 kinase | 0.0198 | 0.2866 | 0.2829 |
Trichomonas vaginalis | peptidylprolyl isomerase, putative | 0.0062 | 0.0385 | 0.0385 |
Entamoeba histolytica | Phosphatidylinositol 3- and 4-kinase family | 0.0112 | 0.1297 | 0.0948 |
Echinococcus granulosus | peptidyl prolyl cis trans isomerase FKBP1A | 0.0062 | 0.0385 | 0.0335 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0318 | 0.5053 | 0.5053 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm) | 0.0112 | 0.1297 | 0.1188 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0074 | 0.0604 | 0.0228 |
Brugia malayi | FAT domain containing protein | 0.0086 | 0.0836 | 0.0789 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0318 | 0.5053 | 0.5053 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0353 | 0.568 | 0.568 |
Giardia lamblia | GTOR | 0.059 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0469 | 0.7804 | 0.7804 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0319 | 0.5062 | 0.5062 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.047 | 0.7813 | 0.7725 |
Trichomonas vaginalis | immunophilin, putative | 0.0062 | 0.0385 | 0.0385 |
Echinococcus granulosus | peptidyl prolyl cis trans isomerase FKBP4 | 0.0062 | 0.0385 | 0.0335 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Change (functional) | = -4 % | Percentage change of HDL cholesterol levels in obese female zucker rats after 1 week of pre-treatment at a dose of 100 mg/kg/day | ChEMBL. | 15537362 |
Change (functional) | = 10 % | Percentage change of triglycerides in obese female zucker rats after 1 week of pre-treatment at a dose of 100 mg/kg/day | ChEMBL. | 15537362 |
Change (functional) | = 12 % | Percentage change of HDL cholesterol levels in obese female zucker rats after 2 weeks of pre-treatment at a dose of 100 mg/kg/day | ChEMBL. | 15537362 |
Change (functional) | = 27 % | Percentage change of triglycerides in obese female zucker rats after 2 weeks of pre-treatment at a dose of 100 mg/kg/day | ChEMBL. | 15537362 |
Change (functional) | = 36 % | Percentage change of non-HDL cholesterol levels in obese female zucker rats after 1 week of pre-treatment at a dose of 100 mg/kg/day | ChEMBL. | 15537362 |
Change (functional) | = 65 % | Percentage change of non-HDL cholesterol levels in obese female zucker rats after 2 weeks of pre-treatment at a dose of 100 mg/kg/day | ChEMBL. | 15537362 |
Inhibition (functional) | < 50 % | Concentration required for inhibition of lipid synthesis in primary cultures of rat hepatocytes at 300 uM; not active | ChEMBL. | 15537362 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.